在多发性骨髓瘤患者的博尔特佐米布诱导的网状疹
Joseph Han1, Shayan Owji1, Aneesh Agarwal1
1Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Dermatopathology (Basel, Switzerland)
|July 25, 2023
概括
博尔特佐米布可以引起罕见的网状皮肤皮疹. 这份病例报告显示,强效局部皮质类固醇可以有效地管理多发性骨髓瘤患者的这种副作用.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 博尔特佐米布是一种新诊断多发性骨髓瘤的蛋白酶体抑制剂标准.
- 虽然Bortezomib有效,但可能会导致副作用,限制其使用.
研究的目的:
- 报告一个独特的案例的网状喷发后,博特佐米布的管理.
- 为了突出皮肤反应的组织学发现.
- 为这种不良事件提供管理建议.
主要方法:
- 一个62岁的男性患有IgG kappa多发性骨髓瘤的病例报告.
- 从受影响部位进行皮肤活检的组织学检查.
- 用局部使用贝塔梅他二 propionate 0.05% 乳液进行治疗.
主要成果:
- 组织学证实了带有淋巴细胞和乙酸细胞的表面周血管性皮肤炎.
- 网状皮疹通过局部皮质类固醇治疗而消失.
- 患者在不停止药物治疗的情况下继续接受博雷佐米布治疗.
结论:
- 在博尔特佐米布注射部位的非典型网状皮疹是一种可控的副作用.
- 皮肤科医生应该考虑强效局部皮质类固醇治疗.
- 维持博特佐米布治疗对于最佳的多发性骨髓瘤管理至关重要.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
245
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
245
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K


